Skip to main content
. 2023 Feb 28;52(2):355–376. doi: 10.1093/ije/dyad012

Table 2.

Oxygen supplementation among patients who received at least one type of oxygen supplementation

N recorded (%) Female Male Total
Total N (%) 72 484 (40.4) 106 964 (59.6) 179 448
Extracorporeal membrane oxygenation 173 972 (96.9) No 69 984 (99.1) 102 052 (98.7) 172 036 (98.9)
Yes 603 (0.9) 1333 (1.3) 1936 (1.1)
Ever received invasive mechanical ventilation 176 135 (98.2) No 58 745 (82.5) 78 950 (75.2) 137 695 (78.2)
Yes 12 462 (17.5) 25 978 (24.8) 38 440 (21.8)
Ever received non-invasive ventilation 177 313 (98.8) No 56 111 (78.3) 76 922 (72.8) 133 033 (75.0)
Yes 15 594 (21.7) 28 686 (27.2) 44 280 (25.0)
High-flow nasal cannula 163 908 (91.3) No 45 488 (68.5) 62 879 (64.5) 108 367 (66.1)
Yes 20 891 (31.5) 34 650 (35.5) 55 541 (33.9)
Oxygen therapy via mask 45 (0.0) No 17 (89.5) 21 (80.8) 38 (84.4)
Yes 2 (10.5) 5 (19.2) 7 (15.6)
Nasal oxygen therapy 45 (0.0) No 0 (0.0) 2 (7.7) 2 (4.4)
Yes 19 (100.0) 24 (92.3) 43 (95.6)
Other or unspecified type of oxygen supplementation 87 328 (48.7) 38 922 (100.0) 48 406 (100.0) 87 328 (100.0)
Number of types of oxygen supplementation 92 120 (51.3) 1 20 998 (62.6) 33 792 (57.7) 54 790 (59.5)
2 9240 (27.5) 17 672 (30.2) 26 912 (29.2)
3 3203 (9.5) 6836 (11.7) 10 039 (10.9)
4 121 (0.4) 258 (0.4) 379 (0.4)
*

Extracorporeal membrane oxygenation, invasive mechanical ventilation, non-invasive ventilation or high-flow nasal cannula.